Local News
2009-06-18
The First Oral Factor Xa Inhibitor Xarelto® Launched in China
Bayer HealthCare announced today that its novel anticoagulant Xarelto® (rivaroxaban) has been granted approval from the State Food and Drug Administration (SFDA) of China» more
Bayer HealthCare announced today that its novel anticoagulant Xarelto® (rivaroxaban) has been granted approval from the State Food and Drug Administration (SFDA) of China» more
2009-06-05
Bayer China Launches “Country Carbon Footprint” Project, Pioneering CO2 Emissions Control in the Chemical and Pharmaceutical Industry
In conjunction with the “World Environment Day”, Bayer China launched its nation-wide “Country Carbon Footprint” program recently, recording and auditing all the Carbon emissions produced during the production and business activities.» more
In conjunction with the “World Environment Day”, Bayer China launched its nation-wide “Country Carbon Footprint” program recently, recording and auditing all the Carbon emissions produced during the production and business activities.» more
Bayer Global News

Bayer Group
Bayer Global News Overview




Bookmark this page
Advanced search